Gogoro to Announce First Quarter 2025 Financial Results on May 8th at 8 a.m. Eastern Time
TAIPEI, April 29, 2025 /PRNewswire/ -- Gogoro® Inc. (Nasdaq: GGR), a global technology leader in battery swapping ecosystems that enable sustainable mobility solutions for cities, today announced that it will release its financial results for the first quarter ended March 31st, 2025, before markets open on May 8th, 2025. Gogoro's management team will hold an earnings Webcast at 8:00 a.m. Eastern Time on Thursday, May 8th, 2025 to discuss the Company's financial and business results and outlook.
What: Date of Gogoro Q1 2025 Financial Results and Q&A Webcast
When: Thursday, May 8, 2025
Time: 8:00 a.m. Eastern Time / 8:00 p.m. Taipei Standard Time
Webcast: https://edge.media-server.com/mmc/p/xecfyxgt/
Approximately 24 hours after the Q&A session, an archived version of the webcast will be available on the Company's website for approximately two weeks thereafter.
ABOUT GOGORO
Founded in 2011 to rethink urban energy and inspire the world to move through cities in smarter and more sustainable ways, Gogoro leverages the power of innovation to change the way urban energy is distributed and consumed. Recognized by Fortune as a 'Change the World 2024" company; Fast Company as 'Asia-Pacific's Most Innovative Company of 2024"; Frost & Sullivan as the '2024 Global Company of the Year for battery swapping for electric two-wheel vehicles"; and, MIT Technology Review as one of '15 Climate Tech Companies to Watch' in 2024, Gogoro's battery swapping and vehicle platforms offer a smart, proven, and sustainable long-term ecosystem for delivering a new approach to urban mobility. Gogoro has quickly become an innovation leader in vehicle design and electric propulsion, smart battery design, battery swapping, and advanced cloud services that utilize artificial intelligence to manage battery charging and availability. The challenge is massive, but the opportunity to disrupt the status quo, establish new standards, and achieve new levels of sustainable transportation growth in densely populated cities is even greater. For more information, visit www.gogoro.com/news and follow Gogoro on X: @wearegogoro.
View original content to download multimedia: https://www.prnewswire.com/news-releases/gogoro-to-announce-first-quarter-2025-financial-results-on-may-8th-at-8-am-eastern-time-302441213.html
SOURCE Gogoro
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fast Company
an hour ago
- Fast Company
Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut
On Wednesday morning, the cancer diagnostics biotech firm Caris Life Sciences rang Nasdaq's opening bell in New York, marking the company's awaited initial public offering. The diagnostics company's IPO follows the successful debut of fintech companies like Chime Financial and Circle Internet Group, and will test whether investors are ready to embrace biotech companies despite declines in the sector for the last six months. Here's what to know about the listing. What is Caris Life Sciences? Founded in 2008 by David Dean Halbert, the healthcare company utilizes next-generation artificial intelligence (AI) and machine learning for precision medicine. Through molecular analysis, Caris specializes in cancer diagnosis and treatment. According to a recent filing to the Securities and Exchange Commission (SEC), the Irving, Texas-based company currently has over 1,700 employees and over 100 biopharmaceutical partners. The company incurred net losses of $281.9 million and $341.4 million in 2024 and 2023, respectively, on revenue of $412.3 million and $306.1 million. It is expecting additional losses in the future. When is Caris Life Sciences's IPO? Caris Life Sciences shares are expected to begin trading on Wednesday, June 18, with the offering expected to run through June 20. What is Caris Life Sciences's stock ticker? Caris Life Sciences will trade its stock under the ticker CAI. What is the IPO price for CAI? CAI shares were priced at $21, above their previously planned range. The IPO price was planned between the $19 and $20 range, up from the previous $16 and $18 planned price. The current pricing would value Caris Life Sciences at around $5.9 billion. What exchange will the stock trade in? CAI will trade its shared on the Nasdaq Global Select Market.
Yahoo
an hour ago
- Yahoo
Goldman Sachs Recommends Buying Apple, Expects Stock to Climb
Apple Inc. (NASDAQ:AAPL) is one of the . An Apple store displaying the latest in consumer electronics, from smartphones to wearables. Goldman Sachs recently highlighted a group of stocks that its analysts believe still have significant growth potential. The firm views these companies as resilient and recommends that investors act quickly to buy them, with Apple Inc. (NASDAQ:AAPL) being one of the top picks on the list. The firm made the following comment: 'We are Buy-rated on AAPL as we believe that the market's focus on slower product revenue growth masks the strength of the AAPL ecosystem & associated revenue durability & visibility. … .Valuation is attractive relative to AAPL's historical multiple — both on an absolute & relative basis — and compared to key tech peers.' Apple Inc. (NASDAQ:AAPL) is not only a tech giant but also a very solid dividend payer. The stock's dividend yield may be low at 0.52%, but it maintains a 13-year streak of dividend growth. While we acknowledge the potential of AAPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None.
Yahoo
an hour ago
- Yahoo
Is Axon Enterprise Stock Outperforming the Nasdaq?
Scottsdale, Arizona-based Axon Enterprise, Inc. (AXON) is a technology provider in global public safety for law enforcement, military, and civilians. Valued at a market cap of $60.5 billion, the company operates through two segments, Software and Sensors, and TASER. Companies valued at $10 billion or more are generally classified as 'large-cap' stocks, and Axon Enterprise fits this description perfectly. The company is known for its TASER energy weapons. It also provides body-worn cameras, digital evidence management systems, and AI-powered software through its cloud-based Axon Cloud platform. Trump Is Giving Tesla's Robotaxis a Leg Up Ahead of June 22. Should You Buy TSLA Stock Now? Dear Nvidia Stock Fans, Mark Your Calendars for July 16 The Trump Family Is Betting Big on Mobile Phones. Should Apple Stock Investors Be Worried? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. AXON stock has declined 3.6% from its 52-week high of $806.64 recorded on June 9. AXON Enterprise stock has surged 40.1% over the past three months, notably surpassing the broader Nasdaq Composite ($NASX), which increased 9.6% during the same period. In the longer term, AXON stock is up 30.8% on a YTD basis, significantly outperforming NASX's 1.1% return. Additionally, shares of AXON have soared 161.7% over the past 52 weeks, compared to NASX's 9.3% gain over the same period. Despite a few fluctuations, the stock has been trading above its 50-day and 200-day moving averages since last year. Shares of AXON climbed 14.1% following its better-than-expected Q1 2025 results on May 7. It posted record quarterly revenue of $603.6 million, up 31.3% year-over-year, significantly beating Wall Street expectations. The strong performance was driven by growth in Software & Services, robust adoption of TASER 10 and Axon Body 4, and rising demand for its platform sensors. Adjusted EPS came in at $1.41, marking a 22.6% increase from the year-ago quarter and surpassing consensus estimates. Encouraged by the momentum, AXON also raised its full-year 2025 revenue guidance to a range of $2.6 billion to $2.7 billion, up from its previous projection of $2.55 billion to $2.65 billion. Compared to its rival, L3Harris Technologies, Inc. (LHX) has lagged behind AXON stock. LHX stock has increased 13.7% over the past 52 weeks and 19.3% on a YTD basis. Due to AXON's strong performance, analysts are strongly optimistic about its prospects. Among the 15 analysts covering the stock, there is a consensus rating of 'Strong Buy,' and it is currently trading above the mean price target of $735. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
